Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia
Authors:
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 7 (8) , 1260-1265
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Heparin-induced thrombocytopenia associated with interleukin-8-dependent platelet activation in a patient with antiphospholipid syndromeEuropean Journal of Haematology, 2007
- Testing for Heparin-Induced Thrombocytopenia AntibodiesTransfusion Medicine Reviews, 2006
- Heparin-Induced Thrombocytopenia: Frequency and PathogenesisPathophysiology of Haemostasis and Thrombosis, 2006
- Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990sThrombosis Research, 2006
- Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopeniaBlood, 2005
- Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparinBlood, 2005
- Heparin-Induced Thrombocytopenia: Recognition, Treatment, and PreventionChest, 2004
- Platelet activation induced by human antibodies to interleukin-8Blood, 2003
- Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosisJournal of Laboratory and Clinical Medicine, 2001
- Heparin-induced thrombocytopenia: What the serologists have taught usJournal of Laboratory and Clinical Medicine, 1996